Valuation: Bonesupport Holding AB

Market Cap 20.95B 2.08B 1.89B 1.74B 1.57B 2.97B 196B 3.07B 8.31B 105B 7.81B 7.64B 333B P/E 2026 *
64.5x
P/E 2027 * 40.8x
Enterprise Value 20.41B 2.03B 1.84B 1.7B 1.53B 2.89B 191B 2.99B 8.09B 102B 7.61B 7.44B 324B EV / Sales 2026 *
13.4x
EV / Sales 2027 * 9.96x
Free-Float
89.54%
Yield 2026 *
0.46%
Yield 2027 * 0.7%
1 day+1.39%
1 week+0.19%
Current month-1.17%
1 month+28.89%
3 months+43.14%
6 months+34.06%
Current year+70.85%
1 week 310.8
Extreme 310.8
326.8
1 month 246
Extreme 246
340.2
Current year 165
Extreme 165
340.2
1 year 165
Extreme 165
340.2
3 years 150
Extreme 150
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 01/09/2025
Director of Finance/CFO 63 01/11/2018
Chief Operating Officer 51 01/12/2021
Director TitleAgeSince
Director/Board Member 68 01/01/2010
Chairman 70 15/12/2016
Chairman 71 14/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Chief Technology Officer

-20,000 0.0304%
28/8/26 Buy

Public Communications Manager

170 0.0003%
26/8/26 Buy

Director

30 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.39%+0.19%+55.77%+101.13% 2.08B
+1.26%+6.61%+41.12%+135.59% 1,286B
+0.79%+3.45%+46.35%+93.56% 688B
+0.20%+1.28%+27.01%+112.80% 521B
-0.44%+3.69%+39.60%+69.51% 386B
+0.55%+0.70%+59.00%+44.20% 364B
-0.12%+0.74%+26.78%+58.43% 302B
+0.37%+0.37%+3.62%+36.44% 287B
-0.30%+1.14%+38.59%+74.61% 252B
+0.08%+0.71%+34.25%+124.32% 208B
Average +0.38%+1.58%+37.21%+85.06% 430B
Weighted average by Cap. +0.54%+2.98%+37.64%+96.23%

Financials

2026 *2027 *
Net sales 1.52B 151M 137M 127M 114M 215M 14.24B 223M 603M 7.61B 567M 555M 24.14B 2.02B 200M 182M 168M 151M 285M 18.89B 296M 800M 10.09B 752M 736M 32.02B
Net income 328M 32.6M 29.54M 27.33M 24.65M 46.46M 3.07B 48.1M 130M 1.64B 122M 120M 5.21B 520M 51.69M 46.84M 43.33M 39.09M 73.67M 4.87B 76.27M 206M 2.6B 194M 190M 8.26B
Net Debt -541M -53.77M -48.73M -45.07M -40.66M -76.63M -5.07B -79.33M -215M -2.71B -202M -198M -8.6B -867M -86.15M -78.07M -72.21M -65.15M -123M -8.12B -127M -344M -4.34B -323M -316M -13.77B
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
174
Date Price Change Volume
13/11/26 SEK 321.20 +1.39% 171,865
12/11/26 SEK 316.80 -1.12% 198,333
11/11/26 SEK 320.40 +1.91% 203,406
10/11/26 SEK 314.40 -3.02% 412,907
09/11/26 SEK 324.20 +1.12% 261,723
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
321.20SEK
Average target price
374.67SEK
Spread / Average Target
+16.65%
  1. Stock Market
  2. Stocks
  3. BONEX Stock